Pre-clinical tests in mice is one thing, getting a commercially viable product to market is another. the announcement was good but peripheral to the main game. What it does show is that CYP are doing things behind the scenes that at times we are not aware of until announcements, small as they are, are released to market and then it perks everyone up which is good.
Ann: Efficacy for CYP MSC Technology in Preclinical Asthma Study-CYP.AX, page-21
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.010(4.00%) |
Mkt cap ! $43.36M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.5¢ | 24.0¢ | $8.739K | 34.96K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 19841 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 50000 | 1 |
View Market Depth
| Last trade - 15.44pm 18/10/2024 (20 minute delay) ? |
| CYP (ASX) Chart |